change in net working capital and cash tax, before maintenance capex Indorama Ventures 2nd Quarter 2019 MD&A 3 Summary 2Q19 results IVL’s performance for the first half and ongoing progress give us the
considered appropriate by Dhipaya Bodin as a joint venture. It will benefit potential shareholders in the medical device and distribution business. The Company agreed to waive the rights to purchase the
won't set optional cookies unless you enable them. Using this tool will set a cookie on your device to remember your preferences. For more detailed information about the cookies we use, please see our
relatively high delivery project value. Furthermore, in Q2–2020, the Company was affected by the ongoing outbreak of COVID–19 which caused the customers change their work methods and slow down their operation
only 6 ongoing projects and no any additional awarded one. During the 1st quarter, one project had been completed whereas another 5 remaining ones have been under construction to be completed within this